Yüklüyor......
Development of CAR T cells designed to improve antitumor efficacy and safety
Chimeric antigen receptor (CAR) T cell therapy has shown promising efficacy against hematologic malignancies. Antitumor activity of CAR T cells, however, needs to be improved to increase therapeutic efficacy in both hematologic and solid cancers. Limitations to overcome are ‘on-target, off-tumor’ to...
Kaydedildi:
| Yayımlandı: | Pharmacol Ther |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5601024/ https://ncbi.nlm.nih.gov/pubmed/28342824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2017.03.012 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|